Article

Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays

2020-07-02

Abstract excerpt

<h4>Introduction</h4> Commercially available SARS-CoV-2 serological assays based on different viral antigens have been approved for the qualitative determination of anti-SARS-CoV-2 antibodies. However, there is limited published data associating the results from commercial assays with neutralizing antibodies. <h4>Methods</h4> 67 specimens from 48 patients with PCR-confirmed COVID-19 and a positive result by the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87cb5814-0fcb-5bec-8cd9-5da2d31ad162
DOI: 10.1101/2020.07.01.182220

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association between SARS-CoV-2 neutralizing antibodies and commercial serological assaysDOI 10.1101/2020.07.01.182220Read

Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent seraSemantic proximity Read

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology testsSemantic proximity Read

Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological AssaysSemantic proximity Read

Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNASemantic proximity Read

High-Specificity Targets in SARS-CoV-2 N Protein for Serological Antibody DetectionSemantic proximity Read

Improved diagnosis of SARS-CoV-2 by using Nucleoprotein and Spike protein fragment 2 in quantitative dual ELISA testsSemantic proximity Read

Comparison of eleven in vitro diagnostic assays for the detection of SARS-CoV-2 RNASemantic proximity Read

Evaluation of a novel fully automated and ELISA- based assays for detecting anti- SARS- CoV-2 neutralizing antibodiesSemantic proximity Read

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2Semantic proximity Read

Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological testsSemantic proximity Read